Physician

Alan Jeffrey Weinshel, M.D.

According to 2025 Medicare claims, Alan Weinshel, M.D. (NPI: 1164479143) practices cardiology in the Providence-Warwick, RI-MA market, with the plurality of this provider's patient population coming from Bristol, MA. This provider's primary affiliated billing organization is SOUTHCOAST CARDIOLOGY LLC (NPI: 1467887562; TIN: 421776488) and primary practice location at 02740-3373. Weinshel is affiliated with the Southcoast Accountable Care Organization, LLC (ACO ID: A1522), participating under the MSSP model.

Weinshel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 712 traditional Medicare patients, billed 9,500 HCPCS/CPT codes, and received $480,287 in Medicare payments. The top billing code was 78452 (Nuclear medicine studies of heart muscle at rest and with stress and spect). Part D data shows 14,676 prescription claims across 928 beneficiaries totaling $1,392,366 in drug costs, led by Eliquis (Apixaban). DME data shows 309 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $817,949 to $1,392,366. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$365K$730K2015 Medicare payment: $577,232 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $560,561 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $598,063 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $604,728 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $641,578 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $598,338 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $729,925 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $657,543 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $620,616 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $480,287 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201596910,294$577,232
201692410,985$560,561
201788810,802$598,063
201887310,630$604,728
201987210,345$641,578
202085515,538$598,338
202186420,801$729,925
202280919,126$657,543
202378818,404$620,616
20247129,500$480,287

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$749K$1.5M2015 Drug cost: $817,949 (USD; Tot_Drug_Cst)2016 Drug cost: $837,851 (USD; Tot_Drug_Cst)2017 Drug cost: $838,275 (USD; Tot_Drug_Cst)2018 Drug cost: $903,026 (USD; Tot_Drug_Cst)2019 Drug cost: $974,386 (USD; Tot_Drug_Cst)2020 Drug cost: $1,056,198 (USD; Tot_Drug_Cst)2021 Drug cost: $1,247,997 (USD; Tot_Drug_Cst)2022 Drug cost: $1,347,629 (USD; Tot_Drug_Cst)2023 Drug cost: $1,498,303 (USD; Tot_Drug_Cst)2024 Drug cost: $1,392,366 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201574519,523$817,949
201676719,028$837,851
201779715,822$838,275
201880315,101$903,026
201981714,751$974,386
202084214,874$1,056,198
202187214,253$1,247,997
202286713,876$1,347,629
202389914,259$1,498,303
202492814,676$1,392,366

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$16K$33K2015 Medicare payment: $32,858 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $22,911 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $14,070 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $10,678 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $10,843 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $10,327 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $11,928 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $10,900 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $12,687 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $18,430 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
20153081,043$32,858
2016209837$22,911
2017150629$14,070
2018115547$10,678
2019124548$10,843
202098464$10,327
202187403$11,928
202268320$10,900
202348353$12,687
202442309$18,430

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
78452Nuclear medicine studies of heart muscle at rest and with stress and spect224455$190
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more6541,744$94
93306Ultrasound of heart with color-depicted blood flow, rate, direction and valve function424781$89
93015Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician229244$55
93000Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report6751,434$11

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EliquisApixaban39026,942$503,577
JardianceEmpagliflozin1248,557$162,357
EntrestoSacubitril/Valsartan573,960$82,477
XareltoRivaroxaban643,302$59,674
JanuviaSitagliptin Phosphate402,966$53,392

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
A4239Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of serviceNN/R14$6,485
A5057Ostomy pouch, drainable, with extended wear barrier attached, with built in convexity, with filter, (1 piece), eachNN/R11$4,005
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateYN/R31$2,234
A4385Ostomy skin barrier, solid 4 x 4 or equivalent, extended wear, without built-in convexity, eachNN/R12$1,744
A4362Skin barrier; solid, 4 x 4 or equivalent; eachNN/R13$948

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Alan Jeffrey Weinshel, M.D.?

Tedicare shows public-source Medicare data for Alan Jeffrey Weinshel, M.D. (NPI 1164479143), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alan Jeffrey Weinshel, M.D. have ACO affiliation data?

Alan Jeffrey Weinshel, M.D. is shown with ACO affiliation data for Southcoast Accountable Care Organization, LLC (MSSP, ACO ID A1522).

What billing organization is linked to Alan Jeffrey Weinshel, M.D.?

Alan Jeffrey Weinshel, M.D. is linked to SOUTHCOAST CARDIOLOGY LLC (billing NPI 1467887562) in the available physician profile data.

Does Alan Jeffrey Weinshel, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.